Omilia
Omilia Announces $67M Series B for Agentic CX Platform
Omilia announced $67M in Series B financing on August 6, 2026. Omilia announced a $67 million Series B led by Expedition Growth Capital to accelerate global expansion of its agentic CX platform, including a first US office.
Round details
The financing includes backing from Expedition Growth Capital. The company did not publish a valuation with the announcement.
- Round: Series B
- Capital announced: $67M
How the company plans to use the capital
The company said the funding will support growth in North America and globally, including the opening of its first US office in the second half of 2026. The release said the round follows a series of senior go-to-market appointments as the company scales its global commercial organization, and that completion of the transaction is subject to customary conditions.
Why this matters for GTM teams
The company’s CEO said momentum is accelerating, particularly in the US, and the release says its first US office is due to open in the second half of 2026.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Omilia Series B announcement.
Company Info
Investors (1)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


